Ekso Bionics Holdings (NASDAQ:EKSO) has announced its acceptance into the NVIDIA Connect program, enabling access to valuable tools and resources to support a new strategic initiative to build a proprietary foundation for human motion, and integrate related new AI capabilities across its portfolio of Enterprise Health and Personal Health devices.
NVIDIA Connect brings together NIVIDIA’s (NASDAQ:NVDA) advanced software development resources, industry-leading frameworks and software development kits, and global ecosystem to help fuel the growth of member companies and expand the capabilities of their software development teams. Benefits include technical training and engineering guidance to support the development of products, and discounts on NVIDIA software and hardware to accelerate development and increase efficiency.
In a statement, Scott Davis, CEO of Ekso Bionics, said, “We are privileged to join a select group of medical device innovators in the NVIDIA Connect program.”
Mr. Davis added, “While our advanced exoskeleton technology platforms are already state-of-the-art, in some ways we are only just approaching the starting line as we work to build and leverage what we believe will be the industry’s first known foundation model for human motion in physical rehabilitation. We are excited for this journey with NVIDIA Connect and look forward to updating all of our stakeholders as we progress.”
